2973 results found
Leukaemia is the most diagnosed cancer in children and the second most common cancer causing death among children in Australia.1 NHMRC-funded researchers at the Children’s Cancer Institute (CCI), in collaboration with researchers at Flinders University and in European laboratories, developed a highly accurate and sensitive technique – known as minimal residual disease (MRD) testing – that enables doctors to improve anti-cancer treatment for children with the most common type of leukaemia.
Ensuring the ethical, humane and responsible use of animals in health and medical research forms part of the sector’s social licence to operate in Australia.
In Australia, the care and use of animals for scientific purposes, including research, is regulated under state and territory legislation.
This document provides advice on the conduct of animal-based studies to ensure that the studies are rigorous, transparent and reproducible and lead to useful outcomes. It is in line with the Australian Code for the care and use of animals for scientific purposes, 8th edition (2013), which is adopted into legislation across Australia.
The Australian Government has implemented a ban on the use of animals for cosmetic testing. The Commonwealth Department of Health managed the implementation of this ban, with the assistance of NHMRC.
The review of the Australian code for the care and use of animals for scientific purposes (the Code) will be led by the Office of NHMRC with advice from NHMRC’s Animal Welfare Committee. The review will also be informed by an Interdepartmental Committee (IDC) comprising representatives from relevant state, territory and Commonwealth departments and agencies. Additional expert advice may be sought on specific issues as required.
The first 5 years of a child’s life are a critical time period for influencing growth, development and learning.1
MRFF – Emerging Priorities and Consumer Driven Research Initiative – 2024 Post-Acute Sequelae of COVID-19 Grant Opportunity
MRFF – Clinical Trials Activity Initiative – 2025 International Clinical Trial Collaborations Grant Opportunity
The information described in the disclosure log table below has been released by NHMRC under the Freedom of Information Act 1982 and is available for public access.
MRFF and NHMRC – Clinical Trials Activity Initiative – 2025 Australia-UK Platform Studies in Areas of Unmet Clinical Need Grant Opportunity
The Medical Research Future Fund (MRFF) is providing grants of financial assistance to support health and medical research and innovation, with the objective of improving the health and wellbeing of Australians.
An honour roll of peer reviewers (including panel chairs, peer review mentors, external assessors and community observers) who contributed to the National Health and Medical Research Council (NHMRC) peer review processes.
NHMRC developed the Human Research Ethics Application (HREA) form as a concise application to facilitate timely and efficient ethics review for research involving humans. HREA assists researchers to consider the ethical principles of the National Statement on Ethical Conduct in Human Research (2023) in relation to their research.
The advice and resources on this page have been provided for public information and to assist the water sector with community water planning in the absence of official NHMRC advice.
The Community water planner: A tool for small communities to develop drinking water management plans was a web-based tool developed to help assess and manage the risks in remote Australian community water supplies. This tool is no longer available.
The below resources are provided to support Synergy Grant peer reviewers.
The revision of the 2013 Australian Dietary Guidelines (the Guidelines) is being conducted consistent with NHMRC’s guideline development process.